SequelSEC

Chemours Co CC

Chemicals & Allied Products · CIK 0001627223 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$1.59B
Fiscal year ended 2026-06-30
Operating income
Unavailable
Fiscal year ended 2026-06-30
Free cash flow
$114.00M
Fiscal year ended 2026-06-30

Chemours Co (CC) reported revenue of $1.59B and net income of -$274.00M for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Chemours Co’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Chemicals & Allied Products.

Income

Chemours Co income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Revenue$1.59B$1.38B$1.33B$1.50B$1.62B$1.37B$1.36BUnavailableUnavailable$1.36B
Cost of revenue$1.30B$1.17B$1.17B$1.26B$1.34B$1.13B$1.09BUnavailableUnavailable$1.08B
Gross profit$286.00M$212.00M$156.00M$233.00M$278.00M$236.00M$265.00MUnavailableUnavailable$284.00M
Operating incomeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Net income-$274.00M-$29.00M-$47.00M$46.00M-$380.00M-$5.00M-$11.00MUnavailableUnavailable$54.00M
Research & development$27.00M$26.00M$27.00M$26.00M$28.00M$27.00M$26.00MUnavailableUnavailable$28.00M
Weighted-average diluted sharesshares 151.23Mshares 150.77MUnavailableshares 150.78Mshares 150.24Mshares 149.92MUnavailableUnavailableUnavailableshares 150.05M
Pretax income-$1.00M-$22.00M-$67.00M$38.00M-$248.00M$0$1.00MUnavailableUnavailable$70.00M
Income tax expense$273.00M$7.00M-$19.00M-$8.00M$131.00M$5.00M$12.00MUnavailableUnavailable$16.00M
Diluted EPS$-1.81$-0.19$-0.31$0.31$-2.53$-0.03$-0.08UnavailableUnavailable$0.36
Selling, general & administrative$469.00M$147.00M$130.00M$122.00M$424.00M$123.00M$170.00MUnavailableUnavailable$137.00M
General & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

Chemours Co balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Cash & equivalents$671.00M$563.00M$670.00M$613.00M$502.00M$464.00M$713.00MUnavailableUnavailable$746.00M
Total assets$7.15B$7.27B$7.38B$7.55B$7.46B$7.38B$7.51BUnavailableUnavailable$7.98B
Current assets$3.09B$2.93B$3.00B$3.21B$3.10B$2.93B$3.02BUnavailableUnavailable$3.61B
Total liabilities$7.20B$7.05B$7.13B$7.27B$7.23B$6.81B$6.94BUnavailableUnavailable$7.23B
Current liabilities$1.86B$1.61B$1.69B$1.87B$1.83B$1.67B$1.82BUnavailableUnavailable$2.23B
Total equity incl. NCI-$48.00M$216.00M$251.00M$276.00M$230.00M$567.00M$572.00MUnavailableUnavailable$755.00M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Inventory$1.45B$1.54B$1.57B$1.55B$1.56B$1.55B$1.46BUnavailableUnavailable$1.38B
Accounts receivable$773.00M$645.00M$562.00M$817.00M$813.00M$704.00M$619.00MUnavailableUnavailable$813.00M
Goodwill$46.00M$46.00M$46.00M$46.00M$46.00M$46.00M$46.00MUnavailableUnavailable$102.00M
Long-term debt$3.84B$4.10B$4.10B$4.10B$4.11B$4.07B$4.06BUnavailableUnavailable$3.97B
Accounts payable$937.00M$891.00M$954.00M$1.04B$1.02B$1.01B$1.16BUnavailableUnavailable$964.00M

Cash flow

Chemours Co cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Operating cash flow$158.00M-$44.00M$137.00M$146.00M$93.00M-$112.00M$138.00MUnavailableUnavailable-$290.00M
Capital expenditures$44.00M$49.00M$45.00M$41.00M$43.00M$84.00M$109.00MUnavailableUnavailable$102.00M
Investing cash flow$239.00M-$44.00M-$43.00M-$35.00M-$42.00M-$86.00M-$107.00MUnavailableUnavailable-$101.00M
Financing cash flow-$289.00M-$19.00M-$37.00M-$5.00M-$27.00M-$57.00M$85.00MUnavailableUnavailable-$54.00M
Net change in cash$108.00M-$109.00M$59.00M$112.00M$39.00M-$249.00M$97.00MUnavailableUnavailable-$454.00M
Stock-based compensation$7.00M$7.00M$4.00M$5.00M$7.00M$5.00M$3.00MUnavailableUnavailable$1.00M
Common dividends paid$13.00M$13.00M$15.00M$13.00M$13.00M$37.00M$36.00MUnavailableUnavailable$37.00M
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortization$80.00M$79.00M$81.00M$80.00M$91.00M$88.00M$74.00MUnavailableUnavailable$71.00M

Derived

Chemours Co derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Free cash flow$114.00M-$93.00M$92.00MUnavailable$50.00M-$196.00M$29.00MUnavailableUnavailable-$392.00M
Gross margin18.0%15.4%11.7%Unavailable17.2%17.3%19.5%UnavailableUnavailableUnavailable
Operating marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
FCF margin7.2%-6.7%6.9%Unavailable3.1%-14.3%2.1%UnavailableUnavailable-28.8%
SBC / revenue0.4%0.5%0.3%Unavailable0.4%0.4%0.2%UnavailableUnavailableUnavailable
Current ratio1.66x1.82x1.78xUnavailableUnavailableUnavailable1.66xUnavailableUnavailable1.62x
Revenue YoY growth-1.5%1.0%-2.2%UnavailableUnavailable0.4%-0.7%UnavailableUnavailable-12.1%
Net margin-17.2%-2.1%-3.5%3.1%-23.5%-0.4%-0.8%UnavailableUnavailable4.0%
R&D / revenue1.7%1.9%2.0%Unavailable1.7%2.0%1.9%UnavailableUnavailableUnavailable
CapEx / revenue2.8%3.5%3.4%Unavailable2.7%6.1%8.0%UnavailableUnavailableUnavailable
Long-term debt / equityUnavailableUnavailable16.33x14.87xUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailable-21.1%UnavailableUnavailable1200.0%UnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open CC in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-05View SEC filing
10-Q · Filed 2026-05-05View SEC filing
10-K · Filed 2026-02-24View SEC filing
10-Q · Filed 2025-11-06View SEC filing
10-Q · Filed 2025-08-05View SEC filing
10-Q · Filed 2025-05-06View SEC filing

Companies in the same industry

ACNT BCPC BLGO CITR ECVT FMC GURE HUN IOSP LOOP LQMT NGVT

Reconciliation checks needing review

4 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

gross profit bridgeinconsistent2024-09-30

Withheld: cost revenue, revenue could not be reconciled with the rest of this filer’s statement.

balance equationinconsistent2024-09-30

Withheld: assets, equity, liabilities could not be reconciled with the rest of this filer’s statement.

balance equationinconsistent2024-06-30

Withheld: assets, equity, liabilities could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2024-06-30

Withheld: cost revenue, revenue could not be reconciled with the rest of this filer’s statement.